Five Years. Three Funds. One Vision.
Fund I – Launched December 2019 – $150 Million Global mandate across healthcare, HealthTech, MedTech, and drug discovery.
Fund II – Launched June 2024 – $350 Million Scaled deployment with larger cheques and deeper value-add support.
Fund III – Launched December 2025 – $450 Million India-focused vehicle targeting Series A & B opportunities in drug discovery, healthcare, and MedTech.
Total Capital Under Management: US$ 950 Million
Launching Soon
- Fund IV: Next-generation global healthcare innovation vehicle.
- Africa-Focused SPAC: Targeting high-potential healthcare and biotech opportunities across the African continent, leveraging our emerging markets expertise.
